Hi All,
Just trying to understand the ACL assets without HA in the picture, are we undervalued at 10-11c right now?
I am not ruling out a reassessment based on further analysis of the control arm and demography of the cohort etc but I think it would be instructive to look at what worst case means for the immediate future. Oz biotech have had 2 this year with odd control group results in Prana (PBT) as well. Given the time that PBT has taken for any reassessment of the control I am not expecting much from any HA review in the short term.
So, Fonda plus cash plus any R&D grants should be closer to 20c, right?
Regards,
John
- Forums
- ASX - By Stock
- TSN
- Taking HA out of the picture (for now)
Taking HA out of the picture (for now)
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TSN (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
TSN (ASX) Chart |
Day chart unavailable